Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 8:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 1,823 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation
Interventions: Informational Intervention, Survey Administration; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: In Vitro Maturation of Oocytes
Interventions: Fertilo, Medicult IVM; Biological · Device
Lead sponsor: Gameto, Inc.; Industry
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 16
States / cities: Clovis, California • Encino, California • Clearwater, Florida + 12 more

Conditions: Type 1 Diabetes
Interventions: T1CARE; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: HIV
Interventions: HIV knowledge Intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 558 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases, Respiratory Tract Infections
Interventions: Low dose of quadrivalent VLP vaccine, Medium dose of quadrivalent VLP vaccine, High dose of quadrivalent VLP vaccine, Placebo; Biological
Lead sponsor: Medicago; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Otitis Media
Interventions: Acclarent Tympanostomy Tube Delivery System (TTDS).; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: Not listed
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Kirkland, Washington

Conditions: Patients Undergoing Thoracic Surgery, Patients Undergoing Upper Abdominal Surgery
Interventions: Fluoroscopic imaging; Procedure
Lead sponsor: Chicago Anesthesia Pain Specialists; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cigarette Smoking-Related Carcinoma
Interventions: Informational Intervention, Media Intervention, Questionnaire Administration, Smoking Cessation Intervention, Survey Administration, Telephone-Based Intervention, Tobacco Cessation Counseling; Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 191 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: COVID-19 Respiratory Infection, SARS CoV 2 Infection, COVID-19 Vaccine
Interventions: CoV-RBD-scNP-001 and 3M-052-AF; Biological
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Embryonic Mosaicism, Embryo Culture Media, Embryo Morphokinetics, Infertility
Interventions: EmbryoScope Plus, GLOBAL MEDIA, SAGE MEDIA; Device · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Seasonal Allergic Rhinitis
Interventions: bepotastine besilate nasal product - low dose, bepotastine besilate nasal product - medium dose, bepotastine besilate nasal product - high dose, placebo comparator nasal product; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Irvine, California

Conditions: Healthcare Facility Environment - Imaging
Interventions: Light perception, Sound perception, Smell perception, Vibration perception, Voice activation; Other
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Schizophrenia
Interventions: SKL15508, Placebo; Drug
Lead sponsor: SK Life Science, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Glendale, California

Conditions: Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer
Interventions: Investigational informed consent for chemotherapy, Usual, standard-of-care informed consent for chemotherapy; Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 21 Years and older
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 8
States / cities: San Francisco, California • Boston, Massachusetts • Milford, Massachusetts + 4 more

Conditions: Social Media Addiction, Anxiety, Depression Disorder, Wellbeing
Interventions: Mindfulness, Social Media Reduction, Exercise; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stroke
Interventions: human chorionic gonadotropin (hCG), then epoetin alfa (EPO), Saline Placebo; Drug
Lead sponsor: Stem Cell Therapeutics Corp.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Orange, California

Conditions: Pain
Interventions: Art Therapy Intervention; Other
Lead sponsor: Columbia University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Knee
Interventions: Umbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection; Biological
Lead sponsor: R3 Medical Research; Industry
Eligibility: 30 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 5
States / cities: Scottsdale, Arizona • Beverly Hills, California • Fresno, California + 2 more

Conditions: Otitis Media
Interventions: Zmax; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 3 Months to 48 Months
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 2
States / cities: Bardstown, Kentucky • Springfield, Kentucky

Conditions: SARS-CoV-2
Interventions: Enhanced Preservation Media (EPM-IX); Diagnostic Test
Lead sponsor: Convergent Genomics, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 205 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis
Interventions: PLF with autograft, PLF with NeoFuse; Procedure · Biological
Lead sponsor: Mesoblast, Ltd.; Industry
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Type 1 Diabetes Mellitus
Interventions: Donislecel (allogeneic islets of Langerhans for transplant); Biological
Lead sponsor: CellTrans Inc.; Industry
Eligibility: 18 Years to 75 Years
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cancer
Interventions: Social cue prompt and policy, Standard prompts; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 294 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Metastatic Melanoma
Interventions: sunitinib malate, temozolomide; Drug
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations

Fertilo In Vitro Research Study and Trial

T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes

HOPE (Harnessing Online Peer Education): Using Online Social Networks for HIV Prevention and Testing

Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults

Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion

Accuracy of the Thoracic Epidural Catheter Insertion Confirmed by Fluoroscopic Imaging

Increasing Access to Smoking Cessation and Smoke Free Home Services for Low-Income Pregnant Women in Northeast Texas

Pancoronavirus Vaccine Study in Healthy Adults

Media, Morphokinetics, and Mosaicism

Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber

Assessing Environmental Factors in Healthcare Facilities in Order to Improve the Experience of Patients, Staff, and the Quality of Imaging Procedures

A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia

Improving Informed Consent for Palliative Chemotherapy

Change in Social Media Use and Well-being Among College Students Receiving a Two-week Exercise or Mindfulness Intervention

Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients

Art Therapy Pain Management Adolescents Pediatric ED

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis

Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX )

Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion

Islet Transplantation in Type I Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

Social Media Posts About Cancer: Five Timepoints

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma